Oliman, Nelfa .
HRN: 14-01-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2024
METRONIDAZOLE 500MG (TAB)
05/17/2024
05/23/2024
ORAL
500 Mg
TID
E. Coli Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes